Advertisement

CD13/APN in Hematopoetic Cells — Expression, Function, Regulation, and Clinical Aspects

  • Uwe Lendeckel
  • Marco Arndt
  • Beate Firla
  • Carmen Wolke
  • Thomas Wex
  • Siegfried Ansorge
Chapter

Abstract

Alanyl aminopeptidase (aminopeptidase N, APN, CD13, EC 3.4.11.2) is a 967 amino acid type II transmembrane protein which occurs on the cell surface of a broad variety of cells. The zinc-dependent metalloprotease (M1 family of peptidases, clan MA, gluzincins) (Hooper 1994, Rawlings and Barrett 1993) preferentially cleaves neutral amino acids from the N-terminus of oligopeptides. The human APN gene was cloned in 1989 and mapped to chromosome 15(q25–q26) (Look et al 1989, Watt and Willard 1990). The 3560 bp of coding sequence are scattered over 20 exons (Lerche et al. 1996).

Keywords

Acute Myeloid Leukemia U937 Cell Hematopoetic Cell Aminopeptidase Inhibitor Human Coronavirus 229E 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. Aberle, H., Bauer, A., Stappert, J., Kispert, A.,andKemler, R., 1997, beta-catenin is a target for the ubiquitin-proteasome pathway.EMBOJ. 16: 3797–3804.CrossRefGoogle Scholar
  2. Ahmad, S., Wang, L.,and Ward, P.E., 1992, Dipeptidyl(amino)peptidase IV and aminopeptidase M metabolize circulating substance P in vivo.J. Pharmacol. Exp. Ther. 260: 1257–1261.PubMedGoogle Scholar
  3. Ansorge, S., Schön, E.,andKunz, D., 1991, Membrane-bound peptidases of lymphocytes: functional implications.Biomed. Biochim. Ada 50: 799–807.Google Scholar
  4. Aoyagi T., Yoshida S., Nakamura Y., Shigihara Y., Hamada M.,andTakeuchi T., 1990, Probestin, a new inhibitor of aminopeptidase M, produced by streptomyces azureus MH663-2F6.J. Antibiotics XLlll: 143–148.CrossRefGoogle Scholar
  5. Barnes, K., Walkden, B.J., Wilkinson, T.C.,andTurner, A.J., 1997, Expression of endothelin-converting enzyme in both neuroblastoma and glial cell lines and its localization in rat hippocampus.J. Neurochem. 68: 570–577.PubMedCrossRefGoogle Scholar
  6. Bhagwat, S.V., Lahdenranta, J., Giordano, R., Arap, W., Pasqualini, R.,andShapiro, L.H., 2001, CD13/APN is activated by angiogenic signals and is essential for capillary tube formation.Blood 97: 652–659.PubMedCrossRefGoogle Scholar
  7. Bhat, N.K., Thompson, C.B., Lindsten, T., June, C.H., Fujiwara, S., Koizumi, S., Fisher, R.J.,andPapas, T.S., 1990, Reciprocal expression of human ETS1 and ETS2 genes during T-cell activation: regulatory role for the protooncogene etsl.Proc. Natl. Acad. Sci. USA 87: 3723–3727.PubMedCrossRefGoogle Scholar
  8. Chansel, D., Czekalski, S., Vandermeersch, S., Ruffet, E., Fournie-Zaluski, M.C.,andArdaillou, R., 1998, Characterization of angiotensin IV-degrading enzymes and receptors on rat mesangial cells.Am. J. Physiol. 275: F535–F542.PubMedGoogle Scholar
  9. Chen, H., Roques, B.P.,andFournie-Zaluski, M.-C., 1999, Design of the first highly potent and selective aminopeptidase N (EC3.4.11.2) inhibitor.Bioorg. Med. Chem. Letters 9: 1511–1516.CrossRefGoogle Scholar
  10. Collyn d’Hooghe, M., Galiegue-Zouitina, S., Szymiczek, D., Lantoine, D., Quief, S., Loucheux-Lefebvre, M.H.,andKerckaert, J.P., 1997, Quantitative and qualitative variation of ETS-1 transcripts in hematologic malignancies.Leukemia 7: 1777–1785.Google Scholar
  11. Delmas, B., Gelfi, J., Kut, E., Sjöström, H., Noren, O.,andLaude, H., 1994, Determinants essential for the transmissible gastroenteritis virus-receptor interaction reside within a domain of aminopeptidase-N that is distinct from the enzymatic site.J. Virol 68: 5216–5224.PubMedGoogle Scholar
  12. Delmas, B., Gelfi, J., L’Haridon, R., Vogel, L.K., Sjöström, H., Noren, O.,andLaude, H., 1992, Aminopeptidase N is a major receptor for the entero-pathogenic coronavirus TGEV.Nature 357: 417–420.PubMedCrossRefGoogle Scholar
  13. Delmas, B., Gelfi, J., Sjöström, H., Noren, O.,andLaude, H., 1993, Further characterization of aminopeptidase-N as a receptor for coronaviruses.Adv. Exp. Med. Biol. 342: 293–298.PubMedCrossRefGoogle Scholar
  14. Diehl, J.A., Cheng, M, Roussel, M.F.,andSherr, C.J., 1998, Glycogen synthase kinase-3beta regulates cyclin Dl proteolysis and subcellular localization.Genes Dev. 12: 3499–3511.PubMedCrossRefGoogle Scholar
  15. Dkhissi, F., Raynal, S.,andLawrence, D.A., 1999, Altered complex formation between p21waf, p27kip and their partner Gl cyclins determines the stimulatory or inhibitory transforming growth factor-1 growth response of human fibroblasts.Int. J. Oncol. 14: 905–910.PubMedGoogle Scholar
  16. Dreno, B., Bureau, B., Stalder, J.F.,andLitoux, P., 1990, MY7 monoclonal antibody for diagnosis of cutaneous T-cell lymphoma.Arch. Dermatol. 126: 1454–1456.PubMedCrossRefGoogle Scholar
  17. Drexler, H.G., Thiel, E.,andLudwig, W.-D., 1991, Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia.Leukemia 5: 637–645.PubMedGoogle Scholar
  18. Dybkaer, K., Kristensen, J.S.,andPedersen, F.S., 2001, Single site polymorphisms and alternative splicing of the human CD 13 gene-different splicing frequencies among patients with acute myeloid leukaemia and healthy individuals.Br. J. Haematol. 112: 691–696.PubMedCrossRefGoogle Scholar
  19. Ewen, M.E., 1996, p53-dependent repression of cdk4 synthesis in transforming growth factor-beta-induced Gl cell cycle arrest.Journal of Laboratory and Clinical Medicine 128: 355–360.PubMedCrossRefGoogle Scholar
  20. Fujii, H., Nakajima, M., Saiki, I., Yoneda, J., Azuma, I.,andTsuruo, T., 1995, Human melanoma invasion and metastasis enhancement by high expression of aminopeptidase N/CD13.Clin. Exp. Metast. 13: 337–344.CrossRefGoogle Scholar
  21. Furuhashi, M., Mizutani, S., Kurauchi, O., Kasugai, M., Narita, O.,andTomoda, Y., 1988, In vitro degradation of opioid peptides by human placental aminopeptidase M.Exp. Clin. Endocrinol. 92: 235–237.PubMedCrossRefGoogle Scholar
  22. Geiser, A. G., Busam, K.J., Kim, S.J., Lafiyatis, R., O’Reilly, M.A., Webbink, R., Roberts, A.B.,andSporn, M.B., 1993, Regulation of the transforming growth factor-beta 1 and -beta3 promoters by transcription factor Spl.Gene 129: 223–228.PubMedCrossRefGoogle Scholar
  23. Giros, B., Gros, C., Solhonne, B.,andSchwartz, J.C., 1986, Characterization of aminopeptidases responsible for inactivating endogenous (Met5)enkephalin in brain slices using peptidase inhibitors and anti-aminopeptidase M antibodies.Mol. Pharmacol. 29: 281–287.PubMedGoogle Scholar
  24. Giugni, T.D., Söderberg, C, Ham, D. J., Bautista, R.M., Hedlund, K.-O., Möller, E.,andZaia, J.A., 1996, Neutralization of human cytomegalovirus by human CD13-specific antibodies.J. Infect. Diseases 173: 1062–1071.CrossRefGoogle Scholar
  25. Goding, J.W.,andHoward, M.C., 1998, Ecto-enzymes of lymphoid cells.Immunol. Rev. 161: 5–10.PubMedCrossRefGoogle Scholar
  26. Guyotat, D., Campos, L., Shi, Z.H., Charrin, C, Treille, D., Magaud, J.P.,andFiere, D., 1990, Myeloid surface antigen expression in adult acute lymphoblastic leukemia.Leukemia 4: 664–666.PubMedGoogle Scholar
  27. Han, J.W., Ahn, S.H., Kim, Y.K., Bae, G.U., Yoon, J.W., Hong, S., Lee, H.Y., Lee, Y.W.,andLee, H.W., 2001, Activation ofp21SuperWAFI/Cip1transcription through Spl sites by histone deacetylase inhibitor apicidin: Involvement of protein kinase C. J. Biol. Chem. in press.Google Scholar
  28. Hedge, S.P., Kumar, A., Kurschner, C.,andShapiro, L.H., 1998, c-Maf interacts with c-Myb to regulate tanscription of an early myeloid gene during differentiation.Mol. Cell. Biol. 18: 2729–2737.PubMedGoogle Scholar
  29. Hirai, H,andSherr, C.J., 1996, Interaction of D-type cyclins with a novel myb-like transcription factor, DMP1.Mol. Cell. Biol. 16: 6457–6467.PubMedGoogle Scholar
  30. Hoeflich, K. P., Luo, J., Rubie, E.A., Tsao, M.S., Jin, O.,andWoodgett, J.R., 2001, Requirement for glycogen synthase kinase-3beta in cell survival and NF-kappaB activation.Nature 406: 86–90.CrossRefGoogle Scholar
  31. Hoffmann, T., Faust, J., Neubert, K.,andAnsorge, S., 1993, Dipeptidyl peptidase IV (CD 26) and aminopeptidase N (CD 13) catalyzed hydrolysis of cytokines and peptides with N-terminal cytokine sequences.FEBSLett. 336: 61–64.CrossRefGoogle Scholar
  32. Hooper, N.M., 1994, Families of zinc metalloproteases.FEBSLett. 354: 1–6.CrossRefGoogle Scholar
  33. Hunt, K.K., Fleming, J. B., Abramian, A., Zhang, L., Evans, D.B.,andChiao, P.J., 1998, Overexpression of the tumor suppressor gene Smad4/DPC4 induces p21wafl expression and growth inhibition in human carcinoma cells.Cancer Res. 58: 5656–5661.PubMedGoogle Scholar
  34. Hussain, M.M., 1985, Reconstitution of purified dipeptidyl peptidase IV. A comparison with aminopeptidase N with respect to morphology and influence of anchoring peptide on function.Biochim. Biophys. Ada 815: 306–312.CrossRefGoogle Scholar
  35. Iavarone, A.,andMassague, J., 1998, E2F and histone deacetylase mediate transforming growth factor beta repression of cdc25A during keratinocyte cell cycle.Mol. Cell. Biol. 19:, 916–922.Google Scholar
  36. Ino K., Goto S., Kosaki A., Nomura S., Asada E., Misawa T., Furuhashi Y., Mizutani S.,andTomoda Y., 1991, Groth inhibitory effect of bestatin on choriocarcinoma cell lines in vitro.Biotherapy 3: 351–357.PubMedCrossRefGoogle Scholar
  37. Ino, K., Isobe, K., Goto, S., Nakashima, I.,andTomoda, Y., 1992, Inhibitory effect of bestatin on the growth of human lymphocytes.Immunopharmacol. 23: 163–171.CrossRefGoogle Scholar
  38. Inoi, K., Goto, S., Nomura, S., Isobe, K., Nawa, A., Okamoto, T.,andTomoda, Y., 1995, Aminopeptidase inhibitor ubenimex (bestatin) inhibits the growth of human choriocarcinoma in nude mice through its direct cytostatic activity.Anticancer Res. 15: 2081–2087.PubMedGoogle Scholar
  39. Ishii, K., Usui, S., Sugimura, Y., Yamamoto, H., Yoshikawa, K.,andHirano, K., 2001, Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells.Biol. Pharm. Bull. 24: 226–230.PubMedCrossRefGoogle Scholar
  40. Ishii, K., Usui, S., Sugimura, Y., Yoshida, S., Hioki, T., Tatematsu, M., Yamamoto, H.,andHirano, K., 2001, Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion.Int. J. Cancer 92: 49–54.PubMedCrossRefGoogle Scholar
  41. Ishizuka, M., Sato, J., Sugiyama, Y., Takeuchi, T.,andUmezawa, H., 1980, Mitogenic effect of bestatin on lymphocytes.J. Antibiotics (Tokyo) 33: 653–662.CrossRefGoogle Scholar
  42. Iwahashi, M., Tanimura, H., Yamaue, H., Tani, M., Noguchi, K., Mizobata, S., Tsunoda, T., Tamai, M.,andArii, K., 1994a, Ubenimex treatment enhances the susceptibility of gastric cancer cell lines to lymphokine-activated killer cells.Anticancer Res. 14: 1563–1568.PubMedGoogle Scholar
  43. Iwahashi, M., Tanimura, H., Yamaue, H., Tsunoda, T., Tani, M, Noguchi, K., Mizobata, S., Tamai, M., Hotta, T.,andArii, K., 1994b, In vitro augmentation of cytotoxic activity of peripheral blood lymphocytes and spleen cells of cancer patients by ubenimex.Anticancer Res. 14: 1557–1562.PubMedGoogle Scholar
  44. Kanayama, N., Kajiwara, Y., Goto, J., el Maradny, E., Maehara, K., Andou, K.,andTerao, T., 1995, Inactivation of interleukin-8 by aminopeptidase N (CD 13).J. Leukoc. Biol. 57: 129–134.PubMedGoogle Scholar
  45. Kawai, M., Hara, Y., Kubota, T., Shiba, K.,andHosaki, S., 1998, A family with high serum leucine aminopeptidase activity derived from a novel variant CD13.Clin. Chem. 44: 215–220.PubMedGoogle Scholar
  46. Kawai, M., Hara, Y., Miyazato, I.,andHosaki, S., 2001, Novel, aberrantly truncated isoform of serum CD13 in a family with high serum aminopeptidase N (CD 13) activity.Clin. Chem. 47: 223–230.PubMedGoogle Scholar
  47. Klausner, R D.,andSitia, R., 1990, Protein degradation in the endoplasmic reticulum.Cell 62:611–614.PubMedCrossRefGoogle Scholar
  48. Koutsodontis, G., Tentes, I., Papakosta, P., Moustakas, A.,andKardassis, D., 2001, Spl plays a critical role in the transcriptional activation of the human cyclin-dependent kinase inhibitor p21(WAFl/Cipl) gene by the p53 tumor suppressor protein.J. Biol. Chem. 276: 29116–29125.PubMedCrossRefGoogle Scholar
  49. Kowalski, J., Belowski, D., Madej, A.,andHerman, Z.S., 1995, Antitumor activity of bestatin and thiorphan in mice.Arch Immunol TherExp (Warsz) 43: 265–271.Google Scholar
  50. Kruse T.A., Larsen L.,andOlsen J., 1992, Polymorphism and genetic mapping of the gene encoding human aminopeptidase N. Abstracts of workshop presentations 1993-1994.Google Scholar
  51. Kumano, N,andSugawara, S., 1992, Ubenimex (Bestatin), an aminopeptidase inhibitor, modulates protein kinase C in K562 cells.J. Biol. Regul. Homeost. Agents 6: 116–120.PubMedGoogle Scholar
  52. Kunz, D., Bühling, F., Hütter, H.J., Aoyagi, T.,andAnsorge, S., 1993, Aminopeptidase N (CD13, EC 3.3.4.11.2) occurs on the surface of resting and concanavalin A-stimulated lymphocytes.Biol. Chem. Hoppe-Seyler 314: 291–296.CrossRefGoogle Scholar
  53. Larsen, S.L., Pedersen, L.O., Buus, S.,andStryhn, A., 1996, T cell responses affected by aminopeptidase N (CD13)-mediated trimming of major histocompatibility complex class 11-bound peptides.J. Exp. Med. 184: 183–189.PubMedCrossRefGoogle Scholar
  54. Lendeckel, U., Arndt, M., Frank, K., Spiess, A., Reinhold, D.,andAnsorge, S., 2000a, Modulation of WNT-5A expression by actinonin: linkage of APN to the WNT-pathway?Adv. Exp. Med. Biol. 477: 35–41.PubMedCrossRefGoogle Scholar
  55. Lendeckel, U., Arndt, M., Frank, K., Wex, T.,andAnsorge, S., 1999, Role of alanyl aminopeptidase in growth and function of human T cells (review).Int. J. Mol. Med 4: 17–27.PubMedGoogle Scholar
  56. Lendeckel, U., Kähne, T., Arndt, M., Frank, K.,andAnsorge, S., 1998, Inhibition of alanyl aminopeptidase induces MAP-kinase p42/ERK2 in the human T cell line KARPAS-299.Biochem. Biophys. Res. Commun. 252: 5–9.PubMedCrossRefGoogle Scholar
  57. Lendeckel, U, Scholz, B., Arndt, M., Frank, K., Spiess, A., Chen, H., Roques, B.P.,andAnsorge, S., 2000b, Inhibition of alanyl-aminopeptidase suppresses the activationdependent induction of glycogen synthase kinase-3beta (GSK-3beta) in human T cells.Biochem. Biophys. Res. Commun. 273: 62–65.PubMedCrossRefGoogle Scholar
  58. Lendeckel, U., Wex, T., Arndt, M., Frank, K., Franke, A.,andAnsorge, S., 1998, Identification of point mutations in the aminopeptidase N gene by SSCP analysis and sequencing.Hum. Mutation Suppl. 1: S158–S160.Google Scholar
  59. Lendeckel, U., Wex, T., Ittenson, A., Arndt, M., Frank, K., Mayboroda, I., Schubert, W.,andAnsorge, S., 1997a, Rapid mitogen-induced aminopepti-dase N surface expression in human T cells is dominated by mechanisms independent of de novo protein biosynthesis.Immunobiol. 197: 55–69.CrossRefGoogle Scholar
  60. Lendeckel U, Wex T, Reinhold D, Arndt, M., Ittenson, A., Frank, K.,andAnsorge, S., 1997, Activation-dependent induction of T cell alanyl aminopeptidase and its possible involvement in T cell growth, in:Adv. Exp. Med. Biol. 421: 59–66.PubMedGoogle Scholar
  61. Lendeckel, U., Wex, Th., Reinhold, D., Kähne, Th., Frank, K., Faust, J., Neubert, K.,andAnsorge, S., 1996, Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation.Biochem. J. 319: 817–823.PubMedGoogle Scholar
  62. Lerche, C., Vogel, L.K., Shapiro, L.H., Noren, O.,andSjöström, H., 1996, Human aminopeptidase N is encoded by 20 exons.Mamm. Genome 7: 712–713.PubMedCrossRefGoogle Scholar
  63. Li, J.M., Hu, P.P., Shen, X., Yu, Y.,andWang, X.F. 1997, E2F4-RB and E2F4-pl07 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.Proc. Nad. Acad. Sci. U.S.A. 94: 4948–4953.CrossRefGoogle Scholar
  64. Look, A.T., Ashmun, R.A., Shapiro, L.H.,andPeiper, S.C., 1989, Human myeloid plasma membrane glycoprotein CD13 (gpl50) is identical to aminopeptidase N.J. Clin. Invest. 83: 1299–1307.CrossRefGoogle Scholar
  65. Löhn, M., Mueller, C., Thiel, K., Kähne, T., Riemann, D.,andLangner, J., 1997, Aminopeptidase N-mediated signal transduction and inhibition of proliferation of human myeloid cells. In:Adv. Exp. Med. Biol. 421: 85–91.PubMedGoogle Scholar
  66. Lucius, R., Sievers, J.,andMentlein, R., 1995, Enkephalin metabolism by microglial aminopeptidase N (CD13).J. Neurochem. 64: 1841–1847.PubMedCrossRefGoogle Scholar
  67. MacArthur, M.W.,andThornton, J.M., 1991, Influence of proline residues on protein conformation.J. Mol. Biol. 218: 397–412.PubMedCrossRefGoogle Scholar
  68. Mahmud, N., Katayama, N., Nishii, K., Sugawara, T., Komada, Y., Mitani, H., Araki, H., Ohishi, K., Watanabe, M., Masuya, M., Nishikawa, M., Minami, N., Ohashi, H.,andShiku, H., 1999, Possible involvement of bcl-2 in regulation of cell-cycle progression of haemopoietic cells by transforming growth factor-beta 1.Br. J. Haematol. 105: 470–477.PubMedCrossRefGoogle Scholar
  69. Mao, CD., Hoang, P.,andDiCorleto, P.E., 2001, Lithium inhibits cell cycle progression and induces stabilization of p53 in bovine aortic endothelial cells.J. Biol. Chem. 276: 26180–26188.PubMedCrossRefGoogle Scholar
  70. Mathe, G., 1987, Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?Cancer Detect. Prevent. Suppl. 1: 445–455.Google Scholar
  71. Matsushita, A., Nagai, K., Ishikawa, T., Tatsumi, E., Ohno, Y.,andTakahashi, T., 1994, B-cell prolymphocytic leukemia expressing CD 13 antigen.Int. J. Hematol. 60: 157–161.PubMedGoogle Scholar
  72. Miller, B.C., Ackroyd, A., Hersh, L.B.,andCottam, G.L., 1994a, Methionine enkephalin metabolism by murine macrophage ectopeptidase(s).Regul. Pept. 50: 87–98.PubMedCrossRefGoogle Scholar
  73. Miller, B.C., Thiele, D.L., Hersh, L.B.,andCottam, G.L., 1994b, Methionine enkephalin is hydrolyzed by aminopeptidase N on CD4+ and CD8+ spleen T cells.Arch. Biochem. Biophys. 311:174–179.PubMedCrossRefGoogle Scholar
  74. Mizutani, S., Goto, K., Nomura, S., Ino, K., Goto, S., Kikkawa, F., Kurauchi, O., Goldstein, G.,andTomoda, Y., 1993, Possible action of human placental aminopeptidase N in fetoplacental unit.Res. Commun. Chem. Pathol. Pharmacol. 82: 65–80.PubMedGoogle Scholar
  75. Morikawa, K., Morikawa, S., Nakano, A.,andOseko, F., 1989, Bestatin, an inhibitor of aminopeptidase B, suppresses the proliferation and differentiation of human B-cells in vitro.Int. J. Immunopharmacol. 11: 905–913.PubMedCrossRefGoogle Scholar
  76. Murata, M., Kubota, Y., Tanaka, T., Iida Tanaka, K., Takahara, J.,andIrino, S., 1994, Effect of ubenimex on the proliferation and differentiation of U937 human histiocytic lymphoma cells.Leukemia 8: 2188–2193.PubMedGoogle Scholar
  77. Müller, W.E., Zahn, R.K., Arendes, J., Munsch, N.,andUmezawa, H., 1979, Activation of DNA metabolism in T-cells by bestatin.Biochem. Pharmacol. 28: 3131–3137.PubMedCrossRefGoogle Scholar
  78. Nagai, M., Kojima, F., Naganawa, H., Hamada, M., Aoyagi, T.,andTakeuchi, T., 1997, Phebestin, a new inhibitor of aminopeptidase N, produced by Streptomyces sp. MJ716-m3.J. Antibiotics 50: 82–84.CrossRefGoogle Scholar
  79. Ohteki, T., Parsons, M., Zakarian, A., Jones, R.G., Nguyen, L.T., Woodgett, J.R.,andOhashi, P.S., 2000, Negative regulation of T cell proliferation and interleukin 2 production by the serine threonine kinase GSK-3.J. Exp. Med. 192: 99–104.PubMedCrossRefGoogle Scholar
  80. Okamura, S., Omori, F., Haga, K., Baba, H., Sugimachi, K.,andNiho, Y., 1990, Influence of bestatin on production of granulocyte-macrophage colony-stimulating factor from human peripheral blood mononuclear cells in vitro.Ada Oncologica 29: 795–797.CrossRefGoogle Scholar
  81. Okamura, T., Shibuya, T., Harada, M.,andNiho, Y., 1992, Successful treatment of chronic adult T-cell leukemia with ubenimex.Acta Haematol. 87: 94–97.PubMedCrossRefGoogle Scholar
  82. Olsen, J., Classen-Linke, I., Sjöström, H.,andNoren, O., 1995, Pseudopregnancy induces the expression of hepatocyte nuclear factor-1 beta and its target gene aminopeptidase N in rabbit endometrium via the epithelial promoter.Biochem. J. 312: 31–37.PubMedGoogle Scholar
  83. Olsen, J., Cowell, G.M., Königshofer, E., Danielsen, E.M., Moller, J., Laustsen, L., Hansen, O.C., Welinder, K.G., Engberg, J.,andHunziker, W., 1988, Complete amino acid sequence of human intestinal amino-peptidase N as deduced from cloned cDNA..FEBS Lett. 238:307–314.PubMedCrossRefGoogle Scholar
  84. Olsen, J., Kokholm, K., Troelsen, T.,andLaustsen, L., 1997, An enhancer with cell-type dependent activity is located between the myeloid and epithelial aminopeptidase N (CD 13) promoters. Biochem. J. 322: 899–908.PubMedGoogle Scholar
  85. Olsen, J., Laustsen, L., Karnstrom, U., Sjostrom, H.,andNoren, O., 1991, Tissue-specific interactions between nuclear proteins and the aminopeptidase N promoter.J. Biol. Chem. 266: 18089–18096.PubMedGoogle Scholar
  86. Palmieri, F.E., Bausback, H.H.,andWard, P.E., 1989, Metabolism of vasoactive peptides by vascular endothelium and smooth muscle aminopeptidase M.Biochem. Pharmacol. 38: 173–180.CrossRefGoogle Scholar
  87. Palmieri, F.E., Petrelli, J.J.,and Ward, P.E., 1985, Vascular, plasma membrane aminopeptidase M. Metabolism of vasoactive peptides.Biochem. Pharmacol. 34: 2309–2317.PubMedCrossRefGoogle Scholar
  88. Papas, T.S., Watson, D.K., Sacchi, N., Fujiwara, S., Seth, A.K., Fisher, R.J., Bhat, N.K., Mavrothalassitis, G., Koizumi, S.,andJornvall, H., 1990, ETS family of genes in leukemia and Down syndrome.Am. J. Med. Genet. Suppl. 7: 251–261.PubMedGoogle Scholar
  89. Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R.A., Shapiro, L.H., Arap, W.,andRuoslahti, E, 2000, Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.Cancer Res. 60: 722–727.PubMedGoogle Scholar
  90. Pasqualini, R., Koivunen, E.,andRuoslahti, E., 1995, A peptide isolated from phage display libraries is a structural and functional mimic of an RGD-binding site on integrins.J. Cell Biol. 130:1189–1196.PubMedCrossRefGoogle Scholar
  91. Pinto, A., Del Vecchio, L., Carbone, A., Roncadin, M., Volpe, R., Serraino, D., Monfardini, S., Colombatti,andA., Zagonel, V., 1991, Expression of myelomonocytic antigens is associated with unfavourable clinicoprognostic factors in B-cell chronic lymphocytic leukaemia.Ann. Oncol. 2 Suppl 2: 107–113.PubMedCrossRefGoogle Scholar
  92. Rawlings, N.D.,andBarrett, A.J., 1993, Evolutionary families of peptidases.Biochem. J. 290:205–218.PubMedGoogle Scholar
  93. Riemann, D., Göhring, B.,andLangner, J., 1994, Expression of aminopeptidase N/CD13 in tumour-infiltrating lymphocytes from human renal cell carcinoma.Immunol. Lett. 42: 19–23.PubMedCrossRefGoogle Scholar
  94. Riemann, D., Kehlen, A.,andLangner, J., 1999, CD 13 - not just a marker in leukemia typing.Immunol. Today 20: 83–88.PubMedCrossRefGoogle Scholar
  95. Riemann, D., Kehlen, A., Thiele, K., Löhn, M.,andLangner, J., 1997, Co-incubation of lymphocytes with fíbroblast-like synoviocytes and other cell types can induce lymphocytic surface expression of aminopeptidase N/CD13. In:Adv. ExpMed. Biol. 421:75-9: 75–79.Google Scholar
  96. Riemann, D., Schwachula, A., Hentschel, M.,andLangner, J., 1993, Demonstration of CD13/aminopeptidase N on synovial fluid T cells from patients with different forms of joint effusions.Immunobiol. 187: 24–35.CrossRefGoogle Scholar
  97. Riemann, D., Wollert, H.G., Menschikowski, J., Mittenzwei, S.,andLangner, J., 1994, Immunophenotype of lymphocytes in pericardial fluid from patients with different forms of heart disease.Int. Arch. Allergy Immunol. 104: 48–56.PubMedCrossRefGoogle Scholar
  98. Romano-Sica, V., Georgiou, P., Suzuki, H., Papas, T.S.,andBhat, N.K., 1995, Role of ETS1 in IL-2 gene expression.J. Immunol. 154: 2724–2732.Google Scholar
  99. Saiki, I., Fujii, H., Yoneda, J., Abe, F., Nakajima, M., Tsuruo, T.,andAzuma, I., 1993, Role of aminopeptidase N (CD 13) in tumor-cell invasion and extracellular matrix degradation.Int. J. Cancer 54: 137–143.PubMedCrossRefGoogle Scholar
  100. Saito, M., Aoyagi, T., Umezawa, H.,andNagai, Y., 1976, Bestatin, a new specific inhibitor of aminopeptidases, enhances activation of small lymphocytes by concanavalin A.Biochem. Biophys. Res. Commun. 76: 526–533.PubMedCrossRefGoogle Scholar
  101. Sakurada K., Imamura M., Kobayashi M., Tachibana N., Abe K., Tanaka M., Okabe M., Morioka M., Kasai M.,andSugiura T., 1990, Inhibitory effect of bestatin on the growth of human leukemic cells.Ada Oncologica 29: 799–802.CrossRefGoogle Scholar
  102. Santos, A.N., Langner, J., Herrmann, M.,andRiemann, D., 2000, Aminopeptidase N/CD13 is directly linked to signal transduction pathways in monocytes.Cell Immunol. 201: 22–32.PubMedCrossRefGoogle Scholar
  103. Shapiro, L.H., 1995, Myb and Ets proteins cooperate to transactivate an early myeloid gene.J. Biol. Chem. 270: 8763–8771.PubMedGoogle Scholar
  104. Shapiro, L.H., Ashmun, R.A., Roberts, W.M.,andLook, A.T., 1991, Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells.J. Biol. Chem. 266: 11999–12007.PubMedGoogle Scholar
  105. Shibanoki, S., Weinberger, S.B., Ishikawa, K.,andMartinez, J.L., Jr., 1991, Further characterization of the in vitro hydrolysis of [Leu]- and [Metjenkephalin in rat plasma: HPLC-ECD measurement of substrate and metabolite concentrations.Regulat. Peptides 32: 267–278.CrossRefGoogle Scholar
  106. Shimamura, M., Hazato, T.,andIwaguchi, T., 1988, A new aminopeptidase in monkey cerebral membrane fraction: hydrolysis of enkephalin.Brain Res. 445: 350–353.PubMedCrossRefGoogle Scholar
  107. Shimamura, M., Hazato, T.,andIwaguchi, T., 1991, Enkephalin-degrading aminopeptidase in the longitudinal muscle layer of guinea pig small intestine: its properties and action on neuropeptides.J. Biochem. Tokyo. 109: 492–497.PubMedGoogle Scholar
  108. Shipp, M.A.,andReinherz, E.L., 1987, Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and Til activation signals.J. Immunol. 139:2143–2148.PubMedGoogle Scholar
  109. Sjöström, H.,andNoren, O., 1982, Changes of the quaternary structure of microvillus aminopeptidase in the membrane.Eur. J. Biochem. 122: 245–250.PubMedCrossRefGoogle Scholar
  110. Sjöström, H., Noren,andO., Olsen, J., 2000, Structure and function of aminopeptidase N.Adv. Exp. Med. Biol. 411: 25–34.Google Scholar
  111. Söderberg, C., Giugni, T.D., Zaia, J.A., Larsson, S., Wahlberg, J.M.,andMöller, E., 1993, CD 13 (human aminopeptidase N) mediates human cytomegalovirus infection.J. Virol. 67: 6576–6585.PubMedGoogle Scholar
  112. Thomas, G.M., Frame, S., Goedert, M, Nathke, I., Polakis, P.,andCohen, P., 1999, A GSK3- binding peptide from FRAT1 selectively inhibits the GSK3-catalysed phosphorylation of axin and beta-catenin.FEBS Lett. 458: 247–251.PubMedCrossRefGoogle Scholar
  113. Tieku, S.,andHooper, N.M., 1992, Inhibition of aminopeptidases N, A, and W.Biochem. Pharmacol 44: 1725–1730.PubMedCrossRefGoogle Scholar
  114. Udvadia, A.J., Rogers, K.T., Higgins, P.D., Murata, Y., Martin, K.H., Humphrey, P.A.,andHorowitz, J.M., 1993, Sp-1 binds promoter elements regulated by the RB protein and Sp-1-mediated transcription is stimulated by RB coexpression.Proc. Natl. Acad. Sci. U.S.A. 90: 3265–3269.PubMedCrossRefGoogle Scholar
  115. Ward, P.E., Benter, I.F., Dick, L.,andWilk, S., 1990, Metabolism of vasoactive peptides by plasma and purified renal aminopeptidase M.Biochem. Pharmacol. 40: 1725–1732.PubMedCrossRefGoogle Scholar
  116. Watanabe, Y., Iwaki-Egawa, S., Mizukoshi, H.,andFujimoto, Y., 1995, Identification of an alanine aminopeptidase in human maternal serum as a membrane-bound aminopeptidase N.Biol. Chem. Hoppe-Seyler 376: 397–400.PubMedCrossRefGoogle Scholar
  117. Watt, V.M.,andWillard, H.F., 1990, The human aminopeptidase N gene: isolation, chromosome localization, and DNA polymorphism analysis.Hum. Genet. 85: 651–654.PubMedCrossRefGoogle Scholar
  118. Werfel, T., Sonntag, G., Weber, M.H.,andGotze, O., 1991, Rapid increases in the membrane expression of neutral endopeptidase (CD10), aminopeptidase N (CD13), tyrosine phosphatase (CD45), and Fc gamma-RIII (CD16) upon stimulation of human peripheral leukocytes with human C5a.J. Immunol. 147: 3909–3914.PubMedGoogle Scholar
  119. Wex, T., Lendeckel, U., Reinhold, D., Kähne, T., Arndt, M., Frank, K.,andS., 1997, Antisense-mediated inhibition of aminopeptidase N (CD 13) markedly decreases growth rates of hematopoietic tumour cells, in Ansorge S, Langner J. (eds): Cellular peptidases in immune function and diseases. New York, Plenum Press, 1997, pp 67–73Google Scholar
  120. Wex, T., Lendeckel, U., Wex, H., Frank, K.,andAnsorge, S., 1995, Quantification of aminopeptidase N mRNA in T cells by competitive PCR. FEBS Lett. 374: 341–344.PubMedCrossRefGoogle Scholar
  121. Yamagishi, H., Naito, K., Ueda, Y., Itoi, S., Kohnosu, H., Kobayashi, M., Kubo, H., Matsuda, A.,andOka, T., 1991, Bestatin administration and the change in cellular immunity.Biomed. Pharmacother. 45: 117–120.PubMedCrossRefGoogle Scholar
  122. Yang, C., Shapiro, L.H., Rivera, M., Kumar, A.,andBrindle, P.K., 1998, A role for CREB binding protein and p300 transcriptional coactivators in Ets-1 transactivation functions.Mol. Cell. Biol. 18: 2218–2229.PubMedGoogle Scholar
  123. Yeager, C.L., Ashmun, R.A., Williams, R.K., Cardellichio, C.B., Shapiro, L.H., Look, A.T.,andHolmes, K.V., 1992, Human aminopeptidase N is a receptor for human coronavirus 229E.Nature 357: 420–422.PubMedCrossRefGoogle Scholar
  124. Yeh, J.R., Mohan,andR., Crews, CM., 2000, The antiangiogenic agent TNP-470 requires p53 and p21CIP/WAF for endothelial cell growth arrest.Proc. Natl. Acad. Sci. U. S. A. 97: 12782–12787.PubMedCrossRefGoogle Scholar
  125. Yokota, S., Yuan, D., Katagiri, T., Eisenberg, R.A., Cohen, P.L.,andTing, J.P., 1987, The expression and regulation of c-myb transcription in B6/lpr Lyt-2-, L3T4-T lymphocytes.J. Immunol. 139:2810–2817.PubMedGoogle Scholar
  126. Yoshida, S., Nakamura, Y., Naganawa, H., Aoyagi, T.,andTakeuchi, T., 1990, Probestin, a new inhibitor of aminopeptidase M, produced by Streptomyces azureus MH663-2F6. II. Structure determination of probestin.J. Antibiot. Tokyo. 43: 149–153.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2002

Authors and Affiliations

  • Uwe Lendeckel
    • 1
  • Marco Arndt
    • 1
  • Beate Firla
    • 2
  • Carmen Wolke
    • 1
  • Thomas Wex
    • 3
  • Siegfried Ansorge
    • 1
  1. 1.Institute of Experimental Internal MedicineOtto-von-Guericke University MagdeburgMagdeburgGermany
  2. 2.Institute of ImmunologyOtto-von-Guericke University MagdeburgMagdeburgGermany
  3. 3.Clinic of GastroenterologyOtto-von-Guericke University MagdeburgMagdeburgGermany

Personalised recommendations